Effect of Continuous Glucose Monitoring on Course of Glucose in Type 1 Diabetes
Primary Purpose
Type 1 Diabetes, Hypoglycemia
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Real time access to current glucose values during CGMS
Sponsored by
About this trial
This is an interventional treatment trial for Type 1 Diabetes focused on measuring type 1 diabetes, glucose excursion, hypoglycemia awareness, continuous glucose monitoring
Eligibility Criteria
Inclusion Criteria:
- type 1 diabetes
- Age > 18 years
- Informed consent
Exclusion Criteria:
- Diagnosis and/or treatment of a current psychiatric disease
- Severe late complications
Sites / Locations
- FIDAM
- Research Institute of the Diabetes Academy Mergentheim
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
No Intervention
Arm Label
A,1
A,2
Arm Description
Real time access to current measured glucose values; hyperglycemic or hypoglycemic alerts
Retrospective analysis of glucose values
Outcomes
Primary Outcome Measures
Daily time spent in the hypoglycemic glucose range during continuous glucose measurement with and without real time access to glucose values and glucose alarms
Secondary Outcome Measures
Time spent in euglycemic and hyperglycemic glucose range Satisfaction with CGMS Diabetes related distress Treatment satisfaction Anxiety and depressive symptoms
Full Information
NCT ID
NCT00467688
First Posted
April 30, 2007
Last Updated
October 30, 2007
Sponsor
Forschungsinstitut der Diabetes Akademie Mergentheim
1. Study Identification
Unique Protocol Identification Number
NCT00467688
Brief Title
Effect of Continuous Glucose Monitoring on Course of Glucose in Type 1 Diabetes
Official Title
The Effect of Continuous Glucose Monitoring With and Without Real Time Access to Glucose Values and Glucose Alerts on Course of Glucose and Satisfaction With CGMS in Type 1 Diabetic Patients
Study Type
Interventional
2. Study Status
Record Verification Date
October 2007
Overall Recruitment Status
Completed
Study Start Date
February 2007 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
July 2007 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Forschungsinstitut der Diabetes Akademie Mergentheim
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The objective of this cross over study is to access if continuous glucose monitoring (CGMS) with a real time feed back and hypoglycemic as well as hyperglycemic glucose alerts vs. only retrospective analysis of glucose values is able to improve course of glucose with special regard to time spent in hypoglycemic glucose ranges in type 1 diabetic patients with impaired hypoglycemia awareness or a history of severe hypoglycemia. The second objective is to access satisfaction with CGMS during both conditions
Detailed Description
The objective of this cross over study is to access if continuous glucose monitoring (CGMS) with a real time feed back and hypoglycemic as well as hyperglycemic glucose alerts vs. only retrospective analysis of glucose values is able to improve course of glucose with special regard to time spent in hypoglycemic glucose ranges. The second objective is to access satisfaction with CGMS during both conditions.
This study is conducted in an inpatient setting with type 1 diabetic patients. Partisans are asked to have twice a continuous glucose measurement with the GlucoDay System (Menarini Diagnostics). Each measurement period is limited to maximal 48 hours. In one condition the have real time access to current glucose values and alerts are given if glucose is dropping below 70 mg/dl or exceeding 180 mg/dl. During the other condition the participants are blind against their current glucose values and no alerts are given. Glucose course is retrospectively analyzed.
The order of these two conditions is randomized.
Expected outcome:
The primary outcome variable is the daily time spent in hypoglycemic range in type 1 diabetic patients with and without impaired hypoglycemia awareness or a history of severe hypoglycemia. Additionally the patients will also complete questionnaire about satisfaction with CGMS, diabetes related distress, treatment satisfaction, depressive and anxiety symptoms which belongs to the secondary variables.
Inclusion criteria:
Type 1 diabetes
Age > 18 years
Informed consent
Exclusion criteria:
Diagnosis and/or treatment of a current psychiatric disease
Severe late complications
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 1 Diabetes, Hypoglycemia
Keywords
type 1 diabetes, glucose excursion, hypoglycemia awareness, continuous glucose monitoring
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
A,1
Arm Type
No Intervention
Arm Description
Real time access to current measured glucose values; hyperglycemic or hypoglycemic alerts
Arm Title
A,2
Arm Type
No Intervention
Arm Description
Retrospective analysis of glucose values
Intervention Type
Device
Intervention Name(s)
Real time access to current glucose values during CGMS
Intervention Description
One arm gets real time access to current measured glucose values and hypoglycemic or hyperglycemic alerts are elicited, The second arm get´s a retrospective analysis of glucose values
Primary Outcome Measure Information:
Title
Daily time spent in the hypoglycemic glucose range during continuous glucose measurement with and without real time access to glucose values and glucose alarms
Time Frame
during the 48 hours of using blind vs. unblind continuous glucose monitoring
Secondary Outcome Measure Information:
Title
Time spent in euglycemic and hyperglycemic glucose range Satisfaction with CGMS Diabetes related distress Treatment satisfaction Anxiety and depressive symptoms
Time Frame
During and after the 48 hours measurement of CGMS
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
type 1 diabetes
Age > 18 years
Informed consent
Exclusion Criteria:
Diagnosis and/or treatment of a current psychiatric disease
Severe late complications
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas Haak, MD
Organizational Affiliation
Forschungsinstitut der Diabetes Akademie Mergentheim
Official's Role
Principal Investigator
Facility Information:
Facility Name
FIDAM
City
Bad Mergentheim
ZIP/Postal Code
D-97980
Country
Germany
Facility Name
Research Institute of the Diabetes Academy Mergentheim
City
Bad Mergentheim
ZIP/Postal Code
D-97980
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
19425875
Citation
Hermanns N, Kulzer B, Gulde C, Eberle H, Pradler E, Patzelt-Bath A, Haak T. Short-term effects on patient satisfaction of continuous glucose monitoring with the GlucoDay with real-time and retrospective access to glucose values: a crossover study. Diabetes Technol Ther. 2009 May;11(5):275-81. doi: 10.1089/dia.2008.0078.
Results Reference
derived
Learn more about this trial
Effect of Continuous Glucose Monitoring on Course of Glucose in Type 1 Diabetes
We'll reach out to this number within 24 hrs